Aphria Crushes Second-Quarter – Revenue up 152% from Last Year

Aphria (TSX:V: APH) is another one of our favorite cannabis stocks. The second largest medical cannabis company in Canada reported second-quarter results on January 11. Once again, another cannabis company basically crushed it. Lots of good things happening. Revenue was up 152% from last year to $5.3 million. Fourth consecutive quarter of profitability. Announced Part 3 of expansion project to add 200,000 square feet of cultivation. Investors are rewarding the strong performance. Shares are up 14% in 2017 – one of the best performers in the Canadian cannabis industry.